Vascular Surgery & Vein Care
Vascular surgery groups and vein treatment centers providing surgical and minimally invasive care for arterial and venous disease through practice groups and roll-up platforms.
- 5
- Verticals
Overview
Vascular Surgery & Vein Care covers vascular surgery groups and vein-treatment centers providing surgical and minimally invasive care for arterial and venous disease. Office-based labs (OBLs) for peripheral vascular procedures and cash-pay vein/aesthetic treatment have driven private-equity interest.
PE-backed vascular and vein platforms consolidate practices and office-based labs, drawn by procedural ancillary economics. Aging demographics, diabetes, and peripheral-artery disease support demand, though OBL reimbursement and utilization scrutiny are risks.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so vascular and vein care is not separately sized.
Business model & economics
Revenue model
Procedure and OBL reimbursement; cash-pay vein care
Key economics
- Recurring revenue
- Low–Moderate
- EBITDA margin
- 20–30% with OBL ancillaries
- Capex intensity
- Moderate
procedure-driven
Characteristics
- Office-based labs drive procedural economics.
- Cash-pay vein and aesthetic treatment upside.
- OBL reimbursement and utilization scrutiny are risks.
M&A deal context
Who’s acquiring
- PE-backed vascular/vein platforms
- OBL-focused consolidators
- Specialty MSOs
What’s driving deals
- Roll-up for OBL and procedural economics.
- Aging, diabetes, and PAD demand.
- Reimbursement and utilization dynamics.
Verticals in this segment
Find Vascular Surgery & Vein Care acquisition targets
Search Acquisera’s index for companies classified under Vascular Surgery & Vein Care (4.10.28) and build a targeted deal pipeline.
Search companies